Teva Pharmaceutical Industries Limited (TLV:TEVA)
Israel · Delayed Price · Currency is ILS · Price in ILA 5,595.00
-95.00 (-1.67%)
Jul 31, 2025, 5:24 PM IDT
Teva Pharmaceutical Industries Employees
As of December 31, 2024, Teva Pharmaceutical Industries had 35,686 total employees, including 33,892 full-time and 1,794 part-time employees. The number of employees decreased by 786 or -2.16% compared to the previous year.
Employees
35,686
Change (1Y)
-786
Growth (1Y)
-2.16%
Revenue / Employee
1.61M ILS
Profits / Employee
-15.21K ILS
Market Cap
60.21B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 35,686 | -786 | -2.16% |
| Dec 31, 2023 | 36,472 | 1,347 | 3.83% |
| Dec 31, 2022 | 35,125 | -854 | -2.37% |
| Dec 31, 2021 | 35,979 | -2,393 | -6.24% |
| Dec 31, 2020 | 38,372 | -1,667 | -4.16% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Danel (Adir Yeoshua) | 4,290 |
| Kamada | 420 |
| Bait Bakfar | 227 |
| SofWave Medical | 126 |
| BrainsWay | 120 |
| Novolog (Pharm-Up 1966) | 936 |
| Ilex Medical | 178 |
| Epitomee Medical | 42 |
Teva Pharmaceutical Industries News
- 1 day ago - Teva CEO: Our supply chain puts us in a strong position - CNBC
- 1 day ago - Teva raises 2025 EPS outlook and innovative product guidance as company targets $700M in cost savings by 2027 - Seeking Alpha
- 1 day ago - Teva Pharmaceutical Industries Limited (TEVA) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 1 day ago - Teva posts Q2 revenue miss as generic products underperform - Seeking Alpha
- 1 day ago - Why Drugmaker Teva Pharmaceutical Narrowed Full-Year Guidance After Beating Q2 Earnings - Investor's Business Daily
- 1 day ago - Teva Pharm Q2 profit beats estimates as branded drugs gain - Reuters
- 1 day ago - Teva Pharmaceutical Non-GAAP EPS of $0.66 beats by $0.04, revenue of $4.18B misses by $90M - Seeking Alpha
- 2 days ago - Generic Revlimid Fades, But Teva's Broader Generics Outlook Remains Strong - Benzinga